omega-n-methylarginine has been researched along with colforsin daropate in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (colforsin daropate) | Trials (colforsin daropate) | Recent Studies (post-2010) (colforsin daropate) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 29 | 8 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, K; Hirata, K; Kijima, Y; Masai, H; Murata, T; Ohta, S; Shinke, T; Shite, J; Takaoka, H; Yokoyama, M; Yoshikawa, R | 1 |
1 other study(ies) available for omega-n-methylarginine and colforsin daropate
| Article | Year |
|---|---|
Inhibition of endogenous nitric oxide synthase augments contractile response to adenylyl cyclase stimulation without altering mechanical efficiency in patients with idiopathic dilated cardiomyopathy.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Aged; Biomechanical Phenomena; Cardiomyopathy, Dilated; Colforsin; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide Synthase Type III; omega-N-Methylarginine | 2007 |